Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business

The transaction with US-based Viatris required regulatory approvals from the Reserve Bank of India, Competition Commission of India and the US Federal Trade Commission, among others.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oWsa1jI
via IFTTT